APO RESEARCH · REPORT
DNA Sequencing
DNA sequencing is any chemical, enzymatic or technological procedure for determining the linear order of nucleotide bases in DNA.
Product & engineering
Understand the product.
DNA sequencing is any chemical, enzymatic or technological procedure for determining the linear order of nucleotide bases in DNA.
Selected research
Market Outlook & Growth Opportunities
Global DNA Sequencing Market Outlook and Growth Opportunities 2026
Market perspective
DNA sequencing is any chemical, enzymatic or technological procedure for determining the linear order of nucleotide bases in DNA.
Global DNA Sequencing key players include Illumina, Roche, BGI, Pacific Biosciences, etc.
This report provides an overview of the global DNA Sequencing market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of DNA Sequencing and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents DNA Sequencing sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the DNA Sequencing market size, projected growth trends, production technologies, key applications, and end-use industries.
DNA Sequencing Segment by Company
Illumina
Roche
Pacific Biosciences
BGI
Macrogen
Berry Genomics
Novo Gene
DNA Sequencing Segment by Type
First Generation DNA Sequencing
Second Generation DNA Sequencing
Third Generation DNA Sequencing
DNA Sequencing Segment by Application
Oncology DNA Sequencing
Life Science DNA Sequencing
Emerging Application DNA Sequencing
Hereditary Disease Detection DNA Sequencing
DNA Sequencing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global DNA Sequencing status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions DNA Sequencing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify DNA Sequencing significant trends, drivers, influence factors in global and regions.
6. To analyze DNA Sequencing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the DNA Sequencing market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global DNA Sequencing industry.
Chapter 3: Detailed analysis of DNA Sequencing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of DNA Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of DNA Sequencing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- First Generation DNA Sequencing
- Second Generation DNA Sequencing
- Third Generation DNA Sequencing
Applications
- Oncology DNA Sequencing
- Life Science DNA Sequencing
- Emerging Application DNA Sequencing
- Hereditary Disease Detection DNA Sequencing
Companies covered
- Illumina
- Roche
- Pacific Biosciences
- BGI
- Macrogen
- Berry Genomics
- Novo Gene
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global DNA Sequencing Sales Value (2021-2032)
- 1.2.2 Global DNA Sequencing Sales Volume (2021-2032)
- 1.2.3 Global DNA Sequencing Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 DNA Sequencing Market Dynamics
- 2.1 DNA Sequencing Industry Trends
- 2.2 DNA Sequencing Industry Drivers
- 2.3 DNA Sequencing Industry Opportunities and Challenges
- 2.4 DNA Sequencing Industry Restraints
3 DNA Sequencing Market by Company
- 3.1 Global DNA Sequencing Company Revenue Ranking in 2025
- 3.2 Global DNA Sequencing Revenue by Company (2021-2026)
- 3.3 Global DNA Sequencing Sales Volume by Company (2021-2026)
- 3.4 Global DNA Sequencing Average Price by Company (2021-2026)
- 3.5 Global DNA Sequencing Company Ranking (2024-2026)
- 3.6 Global DNA Sequencing Company Manufacturing Base and Headquarters
- 3.7 Global DNA Sequencing Company Product Type and Application
- 3.8 Global DNA Sequencing Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global DNA Sequencing Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 DNA Sequencing Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 DNA Sequencing Market by Type
- 4.1 DNA Sequencing Type Introduction
- 4.1.1 First Generation DNA Sequencing
- 4.1.2 Second Generation DNA Sequencing
- 4.1.3 Third Generation DNA Sequencing
- 4.2 Global DNA Sequencing Sales Volume by Type
- 4.2.1 Global DNA Sequencing Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global DNA Sequencing Sales Volume by Type (2021-2032)
- 4.2.3 Global DNA Sequencing Sales Volume Share by Type (2021-2032)
- 4.3 Global DNA Sequencing Sales Value by Type
- 4.3.1 Global DNA Sequencing Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global DNA Sequencing Sales Value by Type (2021-2032)
- 4.3.3 Global DNA Sequencing Sales Value Share by Type (2021-2032)
5 DNA Sequencing Market by Application
- 5.1 DNA Sequencing Application Introduction
- 5.1.1 Oncology DNA Sequencing
- 5.1.2 Life Science DNA Sequencing
- 5.1.3 Emerging Application DNA Sequencing
- 5.1.4 Hereditary Disease Detection DNA Sequencing
- 5.2 Global DNA Sequencing Sales Volume by Application
- 5.2.1 Global DNA Sequencing Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global DNA Sequencing Sales Volume by Application (2021-2032)
- 5.2.3 Global DNA Sequencing Sales Volume Share by Application (2021-2032)
- 5.3 Global DNA Sequencing Sales Value by Application
- 5.3.1 Global DNA Sequencing Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global DNA Sequencing Sales Value by Application (2021-2032)
- 5.3.3 Global DNA Sequencing Sales Value Share by Application (2021-2032)
6 DNA Sequencing Regional Sales and Value Analysis
- 6.1 Global DNA Sequencing Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global DNA Sequencing Sales by Region (2021-2032)
- 6.2.1 Global DNA Sequencing Sales by Region: 2021-2026
- 6.2.2 Global DNA Sequencing Sales by Region (2027-2032)
- 6.3 Global DNA Sequencing Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global DNA Sequencing Sales Value by Region (2021-2032)
- 6.4.1 Global DNA Sequencing Sales Value by Region: 2021-2026
- 6.4.2 Global DNA Sequencing Sales Value by Region (2027-2032)
- 6.5 Global DNA Sequencing Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America DNA Sequencing Sales Value (2021-2032)
- 6.6.2 North America DNA Sequencing Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe DNA Sequencing Sales Value (2021-2032)
- 6.7.2 Europe DNA Sequencing Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific DNA Sequencing Sales Value (2021-2032)
- 6.8.2 Asia-Pacific DNA Sequencing Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America DNA Sequencing Sales Value (2021-2032)
- 6.9.2 South America DNA Sequencing Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa DNA Sequencing Sales Value (2021-2032)
- 6.10.2 Middle East & Africa DNA Sequencing Sales Value Share by Country, 2025 VS 2032
7 DNA Sequencing Country-level Sales and Value Analysis
- 7.1 Global DNA Sequencing Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global DNA Sequencing Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global DNA Sequencing Sales by Country (2021-2032)
- 7.3.1 Global DNA Sequencing Sales by Country (2021-2026)
- 7.3.2 Global DNA Sequencing Sales by Country (2027-2032)
- 7.4 Global DNA Sequencing Sales Value by Country (2021-2032)
- 7.4.1 Global DNA Sequencing Sales Value by Country (2021-2026)
- 7.4.2 Global DNA Sequencing Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.5.2 USA DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.9.2 France DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.16.2 China DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.19.2 India DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran DNA Sequencing Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt DNA Sequencing Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt DNA Sequencing Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt DNA Sequencing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Illumina
- 8.1.1 Illumina Company Information
- 8.1.2 Illumina Business Overview
- 8.1.3 Illumina DNA Sequencing Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Illumina DNA Sequencing Product Portfolio
- 8.1.5 Illumina Recent Developments
- 8.2 Roche
- 8.2.1 Roche Company Information
- 8.2.2 Roche Business Overview
- 8.2.3 Roche DNA Sequencing Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Roche DNA Sequencing Product Portfolio
- 8.2.5 Roche Recent Developments
- 8.3 Pacific Biosciences
- 8.3.1 Pacific Biosciences Company Information
- 8.3.2 Pacific Biosciences Business Overview
- 8.3.3 Pacific Biosciences DNA Sequencing Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Pacific Biosciences DNA Sequencing Product Portfolio
- 8.3.5 Pacific Biosciences Recent Developments
- 8.4 BGI
- 8.4.1 BGI Company Information
- 8.4.2 BGI Business Overview
- 8.4.3 BGI DNA Sequencing Sales, Value and Gross Margin (2021-2026)
- 8.4.4 BGI DNA Sequencing Product Portfolio
- 8.4.5 BGI Recent Developments
- 8.5 Macrogen
- 8.5.1 Macrogen Company Information
- 8.5.2 Macrogen Business Overview
- 8.5.3 Macrogen DNA Sequencing Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Macrogen DNA Sequencing Product Portfolio
- 8.5.5 Macrogen Recent Developments
- 8.6 Berry Genomics
- 8.6.1 Berry Genomics Company Information
- 8.6.2 Berry Genomics Business Overview
- 8.6.3 Berry Genomics DNA Sequencing Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Berry Genomics DNA Sequencing Product Portfolio
- 8.6.5 Berry Genomics Recent Developments
- 8.7 Novo Gene
- 8.7.1 Novo Gene Company Information
- 8.7.2 Novo Gene Business Overview
- 8.7.3 Novo Gene DNA Sequencing Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Novo Gene DNA Sequencing Product Portfolio
- 8.7.5 Novo Gene Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 DNA Sequencing Value Chain Analysis
- 9.1.1 DNA Sequencing Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 DNA Sequencing Sales Mode & Process
- 9.2 DNA Sequencing Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 DNA Sequencing Distributors
- 9.2.3 DNA Sequencing Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst